F
Fátima Carneiro
Researcher at University of Porto
Publications - 440
Citations - 27038
Fátima Carneiro is an academic researcher from University of Porto. The author has contributed to research in topics: Cancer & Hereditary diffuse gastric cancer. The author has an hindex of 79, co-authored 411 publications receiving 22772 citations. Previous affiliations of Fátima Carneiro include University Medical Center Utrecht & Institute of Molecular Pathology and Immunology of the University of Porto.
Papers
More filters
Journal ArticleDOI
The 2019 WHO classification of tumours of the digestive system.
Iris D. Nagtegaal,Robert D Odze,David S. Klimstra,Valerie Paradis,Massimo Rugge,Peter Schirmacher,Kay Washington,Fátima Carneiro,Ian A. Cree +8 more
TL;DR: For the first time, certain tumour types are defined as much by their molecular phenotype as their histological characteristics; however, histopathological classification remains the gold standard for diagnosis in most instances.
Journal ArticleDOI
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma.
Cristina E. Tognon,Stevan R. Knezevich,David G. Huntsman,Calvin D. Roskelley,Natalya Melnyk,Joan Mathers,Laurence Becker,Fátima Carneiro,Nicol Macpherson,Doug Horsman,Christopher Poremba,Poul H. Sorensen +11 more
TL;DR: Retroviral transfer of ETV6-NTRK3 (EN) into murine mammary epithelial cells resulted in transformed cells that readily formed tumors in nude mice, confirming that EN transformation is compatible with epithelial differentiation.
Journal ArticleDOI
Helicobacter pylori and Interleukin 1 Genotyping: An Opportunity to Identify High-Risk Individuals for Gastric Carcinoma
Ceu Figueiredo,José Carlos Machado,Paul D.P. Pharoah,Raquel Seruca,Sónia Sousa,Ralph Carvalho,Ana Filipa Capelinha,Wim Quint,Carlos Caldas,Leen-Jan van Doorn,Fátima Carneiro,Manuel Sobrinho-Simões +11 more
TL;DR: Combined bacterial/host genotyping may provide an important tool in defining disease risk and targeting H. pylori eradication to high-risk individuals.
Journal ArticleDOI
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)
Mário Dinis-Ribeiro,Miguel Areia,A C de Vries,Ricardo Marcos-Pinto,Matilde Monteiro-Soares,Anthony O'Connor,Carina Pereira,Pedro Pimentel-Nunes,Ricardo Correia,Arzu Ensari,Jean-Marc Dumonceau,José Carlos Machado,Guilherme Macedo,Peter Malfertheiner,Tamara Matysiak-Budnik,Francis Megraud,K. Miki,Colm Antoine O’Morain,Richard M. Peek,Thierry Ponchon,Ari Ristimäki,Ari Ristimäki,B. Rembacken,Fátima Carneiro,Ernst J. Kuipers +24 more
TL;DR: A multidisciplinary group of 63 experts from 24 countries developed evidence-based guidelines on the management of patients with precancerous conditions and lesions of the stomach by means of repeat online voting and a meeting in June 2011 in Porto, Portugal.
Journal ArticleDOI
Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019.
Pedro Pimentel-Nunes,Diogo Libânio,Ricardo Marcos-Pinto,Miguel Areia,Marcis Leja,Gianluca Esposito,Mónica Garrido,Ilze Kikuste,Francis Mégraud,Tamara Matysiak-Budnik,Bruno Annibale,Jean-Marc Dumonceau,Rita Barros,Jean-François Fléjou,Fátima Carneiro,Jeanin E. van Hooft,Ernst J. Kuipers,Mário Dinis-Ribeiro +17 more
TL;DR: Patients with chronic atrophic gastritis or intestinal metaplasia (IM) are at risk for gastric adenocarcinoma, and identification and surveillance of patients with precancerous gastric conditions is cost-effective.